Skip to main content
Top
Published in: Journal of Inherited Metabolic Disease 5/2010

01-10-2010 | FATTY ACID OXIDATION

Pathophysiology of fatty acid oxidation disorders

Author: M. J. Bennett

Published in: Journal of Inherited Metabolic Disease | Issue 5/2010

Login to get access

Abstract

Mitochondrial fatty acid oxidation represents an important pathway for energy generation during periods of increased energy demand such as fasting, febrile illness and muscular exertion. In liver, the primary end products of the pathway are ketone bodies, which are released into the circulation and provide energy to tissues that are not able to oxidize fatty acids such as brain. Other tissues, such as cardiac and skeletal muscle are capable of direct utilization of the fatty acids as sources of energy. This article provides an overview of the pathogenesis of fatty acid oxidation disorders. It describes the different tissue involvement with the disease processes and correlates disease phenotype with the nature of the genetic defect for the known disorders of the pathway.
Literature
go back to reference Bennett MJ, Russell LK, Tokunaga C et al (2006) Reye-like syndrome resulting from novel missense mutations in mitochondrial medium- and short-chain l-3-hydroxy acyl-CoA dehydrogenase. Mol Genet Metab 89:74–79CrossRefPubMed Bennett MJ, Russell LK, Tokunaga C et al (2006) Reye-like syndrome resulting from novel missense mutations in mitochondrial medium- and short-chain l-3-hydroxy acyl-CoA dehydrogenase. Mol Genet Metab 89:74–79CrossRefPubMed
go back to reference Brown NF, Mullur RS, Subramanian I et al (2001) Molecular characterization of L-CPT1 deficiency in six patients: insights into function of the native enzyme. J Lipid Res 42:1134–1142PubMed Brown NF, Mullur RS, Subramanian I et al (2001) Molecular characterization of L-CPT1 deficiency in six patients: insights into function of the native enzyme. J Lipid Res 42:1134–1142PubMed
go back to reference Carruth A, Strauss A, Bennett M, Narayan S, Ernst LM (2009) Mutations in long-chain 3-hydroxyacyl-CoA dehydrogenase and placental maternal floor infarct/massive perivillous fibrin deposition. Proceedings of the Society for Pediatric Pathology Interim Meeting, October, 2009, Philadelphia, PA [abstract] Carruth A, Strauss A, Bennett M, Narayan S, Ernst LM (2009) Mutations in long-chain 3-hydroxyacyl-CoA dehydrogenase and placental maternal floor infarct/massive perivillous fibrin deposition. Proceedings of the Society for Pediatric Pathology Interim Meeting, October, 2009, Philadelphia, PA [abstract]
go back to reference Clayton PT, Eaton S, Aynsley-Green A et al (2001) Hyperinsulinism in short-chain l-3-hydroxyacyl-CoA dehydrogenase deficiency reveals the importance of β-oxidation in insulin secretion. J Clin Invest 108:457–465PubMed Clayton PT, Eaton S, Aynsley-Green A et al (2001) Hyperinsulinism in short-chain l-3-hydroxyacyl-CoA dehydrogenase deficiency reveals the importance of β-oxidation in insulin secretion. J Clin Invest 108:457–465PubMed
go back to reference den Boer MEJ, Wanders RJA, Morris AAM, IJlst L, Heymans HS, Wijburg FA (2002) LCHAD deficiency: clinical presentation and follow up in 50 patients. Pediatrics 109:99–104CrossRef den Boer MEJ, Wanders RJA, Morris AAM, IJlst L, Heymans HS, Wijburg FA (2002) LCHAD deficiency: clinical presentation and follow up in 50 patients. Pediatrics 109:99–104CrossRef
go back to reference Filling C, Keller B, Hirschberg D et al (2008) Role of short-chain hydroxyacyl-CoA dehydrogenase in SCHAD deficiency. Biochem Biophys Res Commun 368:6–11CrossRefPubMed Filling C, Keller B, Hirschberg D et al (2008) Role of short-chain hydroxyacyl-CoA dehydrogenase in SCHAD deficiency. Biochem Biophys Res Commun 368:6–11CrossRefPubMed
go back to reference Gillingham MB, Banta-Wright SA, Hermerath CA et al (2006) CPT1A P479L variant identified in Alaska natives by expanded newborn screening. J Inherit Metab Dis 29(Suppl 1; 85) [abstract] Gillingham MB, Banta-Wright SA, Hermerath CA et al (2006) CPT1A P479L variant identified in Alaska natives by expanded newborn screening. J Inherit Metab Dis 29(Suppl 1; 85) [abstract]
go back to reference Greenberg CR, Dilling LA, Thompson GR et al (2009) The paradox of the carnitine palmitoyltransferase type 1a P479L variant in Canadian Aboriginal populations. Mol Genet Metab 96:201–207CrossRefPubMed Greenberg CR, Dilling LA, Thompson GR et al (2009) The paradox of the carnitine palmitoyltransferase type 1a P479L variant in Canadian Aboriginal populations. Mol Genet Metab 96:201–207CrossRefPubMed
go back to reference Hussain K, Clayton PT, Krywawych S et al (2005) Hyperinsulinism of infancy associated with a novel splice site mutation in the SCHAD gene. J Pediatr 146:706–708CrossRefPubMed Hussain K, Clayton PT, Krywawych S et al (2005) Hyperinsulinism of infancy associated with a novel splice site mutation in the SCHAD gene. J Pediatr 146:706–708CrossRefPubMed
go back to reference Iafolla AK, Thompson RJ, Roe CR (1994) Medium-chain acyl-CoA dehydrogenase deficiency: clinical course in 120 affected children. J Pediatr 124:409–415CrossRefPubMed Iafolla AK, Thompson RJ, Roe CR (1994) Medium-chain acyl-CoA dehydrogenase deficiency: clinical course in 120 affected children. J Pediatr 124:409–415CrossRefPubMed
go back to reference Ibdah J, Bennett MJ, Rinaldo P et al (1999) A fetal fatty acid oxidation disorder as a cause of liver disease in pregnant women. N Engl J Med 340:1723–1731CrossRefPubMed Ibdah J, Bennett MJ, Rinaldo P et al (1999) A fetal fatty acid oxidation disorder as a cause of liver disease in pregnant women. N Engl J Med 340:1723–1731CrossRefPubMed
go back to reference Jethva R, Ficicioglu C (2008) Clinical outcomes of infants with short-chain acyl-coenzyme A dehydrogenase deficiency (SCADD) detected by newborn screening. Mol Genet Metab 95:241–242CrossRefPubMed Jethva R, Ficicioglu C (2008) Clinical outcomes of infants with short-chain acyl-coenzyme A dehydrogenase deficiency (SCADD) detected by newborn screening. Mol Genet Metab 95:241–242CrossRefPubMed
go back to reference Jethva R, Bennett MJ, Vockley J (2008) Short-chain acyl-coenzyme A dehydrogenase deficiency. Mol Genet Metab 95:195–200CrossRefPubMed Jethva R, Bennett MJ, Vockley J (2008) Short-chain acyl-coenzyme A dehydrogenase deficiency. Mol Genet Metab 95:195–200CrossRefPubMed
go back to reference Kapoor RR, James C, Flanagan SE, Ellard S, Eaton S, Hussain K (2009) 3-Hydroxyacyl-coenzyme A dehydrogenase deficiency and hyperinsulinaemic hypoglycemia: characterization of a novel mutation and severe dietary protein sensitivity. J Clin Endocrinol Metab 94:2221–2225CrossRefPubMed Kapoor RR, James C, Flanagan SE, Ellard S, Eaton S, Hussain K (2009) 3-Hydroxyacyl-coenzyme A dehydrogenase deficiency and hyperinsulinaemic hypoglycemia: characterization of a novel mutation and severe dietary protein sensitivity. J Clin Endocrinol Metab 94:2221–2225CrossRefPubMed
go back to reference Matern D, Shehata BM, Shekhawat P, Strauss AW, Bennett MJ, Rinaldo P (2001) Placental floor infarction complicating the pregnancy of a fetus with long-chain 3-hydroxyacyl-CoA dehydrogenase (LCHAD) deficiency. Mol Genet Metab 72:265–268CrossRefPubMed Matern D, Shehata BM, Shekhawat P, Strauss AW, Bennett MJ, Rinaldo P (2001) Placental floor infarction complicating the pregnancy of a fetus with long-chain 3-hydroxyacyl-CoA dehydrogenase (LCHAD) deficiency. Mol Genet Metab 72:265–268CrossRefPubMed
go back to reference McGarry JD, Brown NF (1997) The mitochondrial carnitine palmitoyltransferase system: from concept to molecular analysis. Eur J Biochem 244:1–6CrossRefPubMed McGarry JD, Brown NF (1997) The mitochondrial carnitine palmitoyltransferase system: from concept to molecular analysis. Eur J Biochem 244:1–6CrossRefPubMed
go back to reference Molven A, Matre GE, Duran M et al (2004) Familial hyperinsulinemic hypoglycemia caused by a defect in the SCHAD enzyme of mitochondrial fatty acid oxidation. Diabetes 53:221–227CrossRefPubMed Molven A, Matre GE, Duran M et al (2004) Familial hyperinsulinemic hypoglycemia caused by a defect in the SCHAD enzyme of mitochondrial fatty acid oxidation. Diabetes 53:221–227CrossRefPubMed
go back to reference Oey NA, Ruiter JPN, Attie-Bitach T, IJlst L, Wanders RJA, Wijburg FA (2006) Fatty acid oxidation in the human fetus: implications for fetal and adult disease. J Inherit Metab Dis 29:71–75CrossRefPubMed Oey NA, Ruiter JPN, Attie-Bitach T, IJlst L, Wanders RJA, Wijburg FA (2006) Fatty acid oxidation in the human fetus: implications for fetal and adult disease. J Inherit Metab Dis 29:71–75CrossRefPubMed
go back to reference Olpin SE, Afifi A, Clark S et al (2003) Mutation and biochemical analysis in carnitine palmitoyltransferase type II (CPT II) deficiency. J Inherit Metab Dis 26:543–557CrossRefPubMed Olpin SE, Afifi A, Clark S et al (2003) Mutation and biochemical analysis in carnitine palmitoyltransferase type II (CPT II) deficiency. J Inherit Metab Dis 26:543–557CrossRefPubMed
go back to reference Pedersen CB, Kolvraa S, Kolvraa A et al (2008) The ACADS gene variation spectrum in 114 patients with short-chain acyl-CoA dehydrogenase (SCAD) deficiency is dominated by missense variations leading to protein misfolding at the cellular level. Hum Genet 124:43–56CrossRefPubMed Pedersen CB, Kolvraa S, Kolvraa A et al (2008) The ACADS gene variation spectrum in 114 patients with short-chain acyl-CoA dehydrogenase (SCAD) deficiency is dominated by missense variations leading to protein misfolding at the cellular level. Hum Genet 124:43–56CrossRefPubMed
go back to reference Price NT, van der Leij FR, Jackson VN et al (2002) Anovel brain-expressed protein related to carnitine palmitoyltransferase 1. Genomics 80:433–442CrossRefPubMed Price NT, van der Leij FR, Jackson VN et al (2002) Anovel brain-expressed protein related to carnitine palmitoyltransferase 1. Genomics 80:433–442CrossRefPubMed
go back to reference Rinaldo P, Matern D, Bennett MJ (2002) Fatty acid oxidation disorders. Annu Rev Physiol 64:477–502CrossRefPubMed Rinaldo P, Matern D, Bennett MJ (2002) Fatty acid oxidation disorders. Annu Rev Physiol 64:477–502CrossRefPubMed
go back to reference Shekhawat P, Bennett MJ, Sadovsky V, Nelson DM, Rakheja D, Strauss AW (2003) Human placenta metabolizes fatty acids: implications for fetal fatty acid oxidation disorders and maternal liver diseases. Am J Physiol Endocrinol Metabol 284:E1098–E1105 Shekhawat P, Bennett MJ, Sadovsky V, Nelson DM, Rakheja D, Strauss AW (2003) Human placenta metabolizes fatty acids: implications for fetal fatty acid oxidation disorders and maternal liver diseases. Am J Physiol Endocrinol Metabol 284:E1098–E1105
go back to reference Shekhawat P, Sonne S, Matern D et al (2007) Spontaneous development of intestinal and colonic atrophy and inflammation in the carnitine deficient jvs (OCT2N−/−) mice. Mol Genet Metab 92:315–324CrossRefPubMed Shekhawat P, Sonne S, Matern D et al (2007) Spontaneous development of intestinal and colonic atrophy and inflammation in the carnitine deficient jvs (OCT2N−/−) mice. Mol Genet Metab 92:315–324CrossRefPubMed
go back to reference Snider MD, McGarry JD, Hanson RW (2006) Lipid metabolism 1: synthesis, storage and utilization of fatty acids and triacylglycerols. In: Devlin TM (ed) Textbook of biochemistry with clinical correlations, 6th edn. Wiley, Hoboken, pp 662–694 Snider MD, McGarry JD, Hanson RW (2006) Lipid metabolism 1: synthesis, storage and utilization of fatty acids and triacylglycerols. In: Devlin TM (ed) Textbook of biochemistry with clinical correlations, 6th edn. Wiley, Hoboken, pp 662–694
go back to reference Stanley CA, Lieu YK, Hsu BY et al (1998) Hyperinsulinism and hyperammonemia in infants with regulatory mutations of the glutamate dehydrogenase gene. N Engl J Med 338:1352–1357CrossRefPubMed Stanley CA, Lieu YK, Hsu BY et al (1998) Hyperinsulinism and hyperammonemia in infants with regulatory mutations of the glutamate dehydrogenase gene. N Engl J Med 338:1352–1357CrossRefPubMed
go back to reference Strauss AW, Andresen BS, Bennett MJ (2009) Mitochondrial fatty acid oxidation defects. In: Sarafoglou K, Hoffmann GF, Roth KS (eds) Pediatric endocrinology and inborn errors of metabolism. McGraw-Hill, New York, pp 51–70 Strauss AW, Andresen BS, Bennett MJ (2009) Mitochondrial fatty acid oxidation defects. In: Sarafoglou K, Hoffmann GF, Roth KS (eds) Pediatric endocrinology and inborn errors of metabolism. McGraw-Hill, New York, pp 51–70
go back to reference Thuillier L, Rostane H, Droin V et al (2003) Correlation between genotype, metabolic data, and clinical presentation in carnitine palmitoyltransferase 2 deficiency. Hum Mutat 21:493–501CrossRefPubMed Thuillier L, Rostane H, Droin V et al (2003) Correlation between genotype, metabolic data, and clinical presentation in carnitine palmitoyltransferase 2 deficiency. Hum Mutat 21:493–501CrossRefPubMed
go back to reference Tyni T, Kivela T, Lappi M, Summainen P, Nikoskelainen E, Pihko H (1998) Ophthalmic findings in LCHAD deficiency caused by the G1528C mutation. Ophthalmology 105:810–824CrossRefPubMed Tyni T, Kivela T, Lappi M, Summainen P, Nikoskelainen E, Pihko H (1998) Ophthalmic findings in LCHAD deficiency caused by the G1528C mutation. Ophthalmology 105:810–824CrossRefPubMed
go back to reference Wilcken B, Leung KC, Hammond J, Kamath R, Leonard JV (1993) Pregnancy and fetal LCHAD deficiency. Lancet 341:407–408CrossRefPubMed Wilcken B, Leung KC, Hammond J, Kamath R, Leonard JV (1993) Pregnancy and fetal LCHAD deficiency. Lancet 341:407–408CrossRefPubMed
go back to reference Wilcken B, Haas M, Joy P et al (2007) Outcome of neonatal screening for medium-chain acyl-CoA dehydrogenase deficiency in Australia: a cohort study. Lancet 369:37–42CrossRefPubMed Wilcken B, Haas M, Joy P et al (2007) Outcome of neonatal screening for medium-chain acyl-CoA dehydrogenase deficiency in Australia: a cohort study. Lancet 369:37–42CrossRefPubMed
go back to reference Wood PA, Amendt BA, Rhead WJ, Millington DS, Inoue F, Armstrong D (1989) Short-chain acyl-coenzyme A deficiency in mice. Pediatr Res 25:38–43CrossRefPubMed Wood PA, Amendt BA, Rhead WJ, Millington DS, Inoue F, Armstrong D (1989) Short-chain acyl-coenzyme A deficiency in mice. Pediatr Res 25:38–43CrossRefPubMed
Metadata
Title
Pathophysiology of fatty acid oxidation disorders
Author
M. J. Bennett
Publication date
01-10-2010
Publisher
Springer Netherlands
Published in
Journal of Inherited Metabolic Disease / Issue 5/2010
Print ISSN: 0141-8955
Electronic ISSN: 1573-2665
DOI
https://doi.org/10.1007/s10545-010-9170-y

Other articles of this Issue 5/2010

Journal of Inherited Metabolic Disease 5/2010 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.